The diet of patients with atherosclerotic disease compared with the standard diet in the population;Kostholdet hos pasienter med aterosklerotisk sykdom sammenliknet med befolkningen

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 22, 2000, Pages 2618-2624

  Svilaas, Arne ^a   Bergei, Caroline S ^a   Strøm, Ellen C ^a   Ose, Leiv ^a   Walsøe, Heidi K ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b PAREXEL INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; BLOOD; BRAIN ATHEROSCLEROSIS; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; FAT INTAKE; FEEDING BEHAVIOR; FEMALE; HEALTH SURVEY; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; NORWAY; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ARTERIOSCLEROSIS; CORONARY ARTERIOSCLEROSIS; CROSS-SECTIONAL STUDIES; DIETARY FATS; FEMALE; FOOD HABITS; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; LIFE STYLE; LIPIDS; MALE; MIDDLE AGED; NORWAY; POPULATION SURVEILLANCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034692282     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Scandinavian Simvastatin Survival Study Group: randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
2. Sacks FM, Pfeffer MA, Move LA, Rouleau JL, Rutherford JD, Cole TG et al. The effect of pravastatin on coronary events after acute myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-9.
3. West of Scotland Coronary Prevention Group. West of Scotland Coronary Study: identification of high-risk groups and comparison with other cardiovascular intervention trials. Lancet 1996; 348: 1339-42.
4. Pyörälä K, Pedersen T, Kjekshus, J, Færgeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary disease. The Scandinavian Simvastatin Survival Study (4S) Group. Diabetes Care 1997; 20: 614-20.
5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-57.
6. Wood D, De Backer G, Færgeman O, Graham I, Mancia G, Pyörälä K together with members of the task force. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434-503.
7. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF et al. When to start cholesterol-lowering therapy in patients with coronary heart disease: a statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction. Circulation 1997; 95: 1683-5.
8. Ose L. Behandling av hyperlipidemi. Tidsskr Nor Lægeforen 1995; 115: 3629-31.
9. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. Eur Heart J 1997; 18: 1569-82.
10. Svilaas A, Westheim A, Kristoffersen JE, Hjartaaker J. Risikofaktorer og intervensjon ved hjerte- og karsykdommer i allmennpraksis. Tidsskr Nor Lægeforen 1996; 116: 2562-5.
11. Svilaas A, Westheim A, Kristoffersen JE, Hjartaaker J, Thoresen M. Hvor godt behandles pasienter med aterosklerotisk sykdom i allmennpraksis? Tidsskr Nor Lægeforen 1998; 118: 2308-13.
12. Krefting E, Hansen J-B, Nordøy A. Bruk av statiner etter hjerteinfarkt i sykehus før og etter 4S-studien. Tidsskr Nor Lægeforen 1999; 119: 2986-9.
13. O. Fægeman. Challenges to best practice: why are guidelines not implemented? Eur Heart J 1999; 1 (suppl J): J12-7.
14. Illingworth DR, Durrington PN. Dyslipidemia and atherosclerosis: How much more evidence do we need? Curr Opin Lipidol 1999; 10: 383-6.
15. LaRosa JC. Poor compliance: the hidden risk factor. Current Atherosclerosis Reports 2000; 2: 1-4.
16. Betteridge DJ, Morrell JM. Clinicians' guide to lipids and coronary heart disease. London: Chapman & Hall Medical, 1998: 149-55.
17. Hecker KD, Kris-Etherton PM, Zhao G, Coval S, St. Jeor S. Impact of body weight and weight loss on cardiovascular risk factors. Current Atherosclerosis Reports 1999; 1: 236-42.
18. Kris-Etherton, PM. A new role for diet in reducing the incidence of cardiovascular disease: evidence from recent studies. Current Atherosclerosis Reports 1999; 1: 185-7.
19. Pearson, TA, Bloch R, Dorantes J, Gordian AL, Fang C, Swanson J et al. The rationale for renewed interest by physicians in nutrition. Current Atherosclerosis Reports 1999; 1: 173-5.
20. Stone NJ. Diet, nutritional issues, and obesity. I: Topol E, red. Textbook of cardiovascular medicine. Philadelphia, PA: Lippincott-Raven, 1998: 31-58.
21. Law MR. Lowering heart disease risk with cholesterol reduction: evidence from observational studies and clinical trials. Eur Heart J 1999; 1 (suppl S): S3-8.
22. De Longeril M, Salen P, Martin JP. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Circulation 1999; 99: 779-85.
23. Betteridge DJ, Morrell JM. Clinicians' guide to lipids and coronary heart disease. London: Chapman & Hall Medical, 1998: 157-76.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
25. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999; 341: 427-34.
26. Miller M. Giving triglycerides their due. Hospital Practice 1999: 67-73.
27. Svilaas A, Walsøe HK, Ose L. Application of simple lipid treatment goals in patients with atherosclerotic disease. Nutr Metab Cardiovasc Dis 2000; 10: 71-8.
28. Johansson, L. Utviklingen i norsk kosthold. Rapport nr. 1/1999. Oslo: Statens råd for ernæring og fysisk aktivitet, 1999.
29. Papas AM. Diet and antioxidant status. I: Papas AM, red. Antioxidant status, diet, nutrition, and health. Boca Raton, FL: CRC Press LLC, 1999: 88-106.
30. Eichholzer M, Gutzwiller F. Is a low fat diet enough to achieve serum cholesterol goals? Eur Heart J 1999; 20: 991-4.
31. Lokalt og globalt fokus på år 2000. Mat & mosjon, Statens råd for ernæring og fysisk aktivitet 1999: 4: 9-10.
32. Kromhout D. Diet-hart issues in a pharmacological era. Lancet 1996; 348 (suppl I): 20-2.
33. McCarron DA, Oparil S, Chait A, Haynes RB, Kris-Etherton P, Stern JS et al. Nutritional management of cardiovascular risk factors. Arch Intern Med 1997; 157: 169-77.
34. Smith SC, Greenland P, Grundy SM. AHA Conference proceedings. Prevention conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Executive summary. Circulation 2000; 101: 111-6.
35. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere P et al for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998; 279: 1615-22.
36. Gotto AM jr., Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S et al. Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/ Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation 2000; 101: 477-84.
37. Johansson L, Solvoll K, Bjørneboe, Drevon CA. Dietary habits among Norwegian men and women. Scand J Nutr 1997; 41: 63-70.
38. Miller M, Vogel RA. The practice of coronary disease prevention. Baltimore, MD: Williams & Wilkins, 1996: 225-42.
39. Funke H, Assmann G. Strategies for the assessment of genetic coronary artery disease risk. Curr Opin Lipidol 1999; 10: 285-91.
40. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999; 341: 217-25.
41. LaRosa JC, He J, Vupputuri S. Effects for statins on risk of coronary disease. JAMA 1999; 282: 2340-6.
42. Nesje SB. 20 000 kan bli røykfrie med legenes hjelp. Tidsskr Nor Lægeforen 2000; 120: 402.
43. Vekt - helse. Rapport nr. 1/2000. Oslo: Statens råd for ern̊ring og fysisk aktivitet, 2000.
44. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-105.
45. Thomas GN, Tomlinson B, Critchley JAJH. Guidelines for healthy weight. N Engl J Med 1999; 341: 2097.